Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
Document Type
Article
Publication Date
7-1-1998
Abstract
E-55+ murine leukemia virus infection of both progressor (BALB) and long term nonprogressor (C57BL) mouse strains is characterized by an acute and a persistent phase of infection. During the acute phase, progressor strains require CD8+ T cells to decrease virus burden, whereas the long term nonprogressor strains do not. In the present studies the immune response in BALB and C57BL mice during the acute phase of E-55+ murine leukemia virus infection was examined. The results demonstrate that BALB mice produce both IL-4 and IFN-gamma, in contrast to C57BL mice, which produce only IFN-gamma. In BALB mice, IL-4 production results in the absolute requirement for CD8+ T cells to reduce the virus burden during the acute phase of infection. The anti-virus immune response in these mice is IFN-gamma dependent. On the other hand, C57BL mice do not produce IL-4 and, in the absence of both CD8+ T cells and IFN-gamma, still generate an effective anti-virus immune response. Genetic studies suggest that these distinct immune responses are regulated by more than one non-MHC-linked gene. Two candidate regions that may encode this gene(s), located on chromosomes 7 and 19, respectively, were identified by recombinant inbred strain linkage analysis.
Publication Title
Journal of Immunology
Volume
161
Issue
1
First Page
17
Last Page
26
Recommended Citation
Panoutsakopoulou, Vily; Little, C. Scott PhD; Sieck, Thomas G.; Blankenhorn, Elizabeth P.; and Blank, Kenneth J., "Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice." (1998). PCOM Scholarly Works. 1012.
https://digitalcommons.pcom.edu/scholarly_papers/1012
Comments
This article was published in the Journal of Immunology, Volume 161, Issue 1, July 1998, pages 17-26.
The published version is available at http://www.jimmunol.org/content/161/1/17.long
Copyright © 1998 American Association of Immunologists.